 REDWOOD CITY, Calif., Dec. 08, 2020 GLOBE NEWSWIRE -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced the closing of its initial public offering of 10,592,106 shares of Class A common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,381,579 shares of Class A common stock, at a public offering price of 19.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Seer, were approximately 201.3 million. Seers Class A common stock began trading on the Nasdaq Global Select Market on December 4, 2020, under the ticker symbol SEER. All of the shares of Class A common stock were offered by Seer. 